What You Missed at the AI Convergence: Small Molecule Discovery Summit
The fast-evolving nature of AI/ML tool development for small molecule discovery requires continuous, thought-led learning. Equally, the practical value of industrializing AI/ML approaches to design and optimize truly novel small molecule chemistry is yet to be fully implemented at scale.
The AI Convergence: Small Molecule Discovery Summit was your chance to respond to this industry moment head-on. The summit jumped on the opportunity to gain visibility into how techbio torchbearers, pharma adopters and biotech innovators are harnessing the confluence of insights gained from AI/ML, medicinal chemistry and computational approaches to impact hit-to-lead progression.
It featured applied talks that provided confidence on small molecule discovery innovation from concept to IND, alongside proven wet-lab validation and increased probability of success, that left attendees walking away feeling empowered to advance better, AI-enabled small molecules to patients faster.
What Set This Meeting Apart?
The 2026 Extensive Event Agenda
- 22 World-Class AI/ML-Guided Small Molecule Discovery Speakers
- 2 Days of Exclusive Content Addressing AI/ML Methods, Applications, Tool Convergence & Confidence
- Unmatched Networking & Strategic Partnering Opportunities
- 1 Focused Industry-Lead Community of Top Techbio, Pharma & Biotech Companies
Attending Companies Included:
Discover the 2026 Agenda
Catch the latest industry breakthroughs, emerging trends and exclusive insights through our dynamic roundtables and panel discussions.
Prioritize Partnering With Us
As the field rapidly expands, position yourself alongside leading solution providers to ensure your brand stands out as a premier choice amid growing competition.
Join Biopharma Experts
Immerse yourself in critical conversations with like-minded attendees spanning all stages of the small molecule drug discovery funnel and build invaluable connections during dedicated networking sessions.